1. Ursodeoxycholic acid: a promising therapeutic target for inflammatory bowel diseases?
   Stephen J. Keely et al, 2019, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
2. Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis
   Viviane Lima Batista et al, 2020, Frontiers in Microbiology CrossRef
3. Ursodeoxycholic and chenodeoxycholic bile acids attenuate systemic and liver inflammation induced by lipopolysaccharide in rats
   T Milivojac et al, 2024, Molecular and Cellular Biochemistry CrossRef
4. The Intestinal Redox System and Its Significance in Chemotherapy-Induced Intestinal Mucositis
   Qing-Qing Yu et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
5. Ursodeoxycholic acid and its unexpected application areas
   A. R. Reyzis, 2020, Meditsinskiy sovet = Medical Council CrossRef
6. Lactobacillus delbrueckii CIDCA 133 Ameliorates Chemotherapy-Induced Mucositis by Modulating Epithelial Barrier and TLR2/4/Myd88/NF-κB Signaling Pathway
   Fernanda Alvarenga Lima Barroso et al, 2022, Frontiers in Microbiology CrossRef
7. Potentiation of Glucagon-Like Peptide-2 Dynamics by Methotrexate Administration in Rat Small Intestine
   Maiko Machida et al, 2019, Biological and Pharmaceutical Bulletin CrossRef
8. Myricetin (3,3′,4′,5,5′,7-Hexahydroxyflavone) Prevents 5-Fluorouracil-Induced Cardiotoxicity
   Azher Arafah et al, 2022, ACS Omega CrossRef
9. Lowering propionic acid levels by regulating gut microbiota with ursodeoxycholic acid appears to regress autism symptoms: an animal study
   Levent KARAKAŞ et al, 2023, Journal of Health Sciences and Medicine CrossRef